13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-09-29 Event 2026-09-25 SEC 0001829126-26-010591 →

Lazar David E. → Aterian, Inc. ATER

Stake: 3.10% Shares: 8,038,030 CUSIP: 02156U200 Class: Common Stock, $0.0001 par value

Item 4 — Purpose of Transaction

Item 4 is hereby amended and supplemented as follows: "September 2026 Securities Purchase Agreement On September 1, 2026, the Reporting Person entered into a Securities Purchase Agreement (the "September SPA") with multiple purchasers (the "Purchasers"), pursuant to which the Reporting Person agreed to sell, in a private transaction, (i) 706,100 shares of Series AA Preferred Stock of the Issuer and (ii) 1,750,000 shares of Series AAA Preferred Stock of the Issuer, which are convertible into an aggregate of 241,861,970 shares of Common Stock of the Issuer, to the Purchasers for an aggregate purchase price of $12,000,000. The transactions contemplated by the September SPA occurred on September 25, 2026. The foregoing description of the September SPA does not purport to be complete and is qualified in its entirety by reference to the full text of the September SPA, which is filed as Exhibit 99.5 hereto."

Cross-References

Insider Activity (last 365d)
8 transactions
2 buys · 2 sales · 0 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
9 filings by this filer
8 other filings in the data moat
Short Interest · settle 2026-09-30
DTC 3.55
612,019 shares short · -25.9% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-09-25 Lazar David E. director, officer Sale 1,750,000 $0.01 $26K
2026-09-25 Lazar David E. director, officer Sale 706,100 $0.26 $183K
2026-09-25 NATAN DAVID director Award 301,205 — —
2026-09-24 Lazar David E. director, officer C 1,300,530 — —
2026-09-24 Lazar David E. director, officer C 168,900 — —
2026-08-04 Lazar David E. director, officer, 10%+ owner C 875,000 $2.00 $1.75M
2026-08-04 Lazar David E. director, officer, 10%+ owner C 875,000 $0.26 $227K
2026-07-17 Lazar David E. director, officer, 10%+ owner Award 1,750,000 $0.01 $26K

Other 13D/G Filings on Aterian, Inc.

FiledFormFilerStakeShares
2026-10-02 SCHEDULE 13D Chang Woei Jiann 10.00% 26,121,180 view →
2026-10-02 SCHEDULE 13D Michelle Chiam Sin Ling 10.00% 26,121,180 view →
2026-09-10 SCHEDULE 13D Lazar David E. 95.70% 249,900,000 view →

Other Filings by Lazar David E.

FiledFormIssuerStakeShares
2026-09-10 SCHEDULE 13D Aterian, Inc. 95.70% 249,900,000 view →
2026-08-07 SCHEDULE 13D/A Quantum Cyber N.V. 94.30% 477,000,000 view →
2026-07-02 SCHEDULE 13D/A KALA BIO, Inc. KALA 3.90% 719,404 view →
2026-04-28 SCHEDULE 13D MAINZ BIOMED N.V. QUCY 97.40% 477,000,000 view →
2026-01-29 SCHEDULE NovaBay Pharmaceuticals, Inc. SDEV 4.99% 6,388,000 view →
2025-03-10 SCHEDULE FiEE, Inc. FIEE 35.10% 2,802,254 view →
2024-04-08 SC OPGEN INC CFOR — — view →
2022-07-11 SC EQUUS TOTAL RETURN, INC. EQS — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →